Cardiac Device Implantation: Techniques and Best Practices.

Area of Science:

• Cardiology
• Medical Device Technology

Background:

• Transvenous leads are the standard for delivering bradyarrhythmia and tachyarrhythmia device therapy.
• Cardiac implantable electronic devices (CIED) are associated with risks of infection, complications during transvenous lead extraction (TLE), and mortality.
• These risks arise from a combination of patient-specific factors and implant-related issues.

Purpose of the Study:

• To explore the complex interplay of factors contributing to CIED infections and TLE complications.
• To identify modifiable and non-modifiable risk factors influencing procedural safety and patient outcomes.
• To emphasize strategies for enhancing the safety of CIED implantation and subsequent management.

Main Methods:

• Review of existing literature on transvenous lead therapy, CIED infections, and TLE.
• Analysis of patient-related risk factors (non-modifiable).
• Evaluation of implant-related characteristics and adverse events (modifiable).

Main Results:

• Risk factors for CIED infection and TLE complications are multifactorial.
• Patient-related factors and implant-related characteristics significantly influence outcomes.
• Adverse events during implantation and extraction contribute to mortality risk.

Conclusions:

• Careful patient screening is crucial for mitigating risks associated with CIED.
• Implementing robust infection mitigation strategies is essential for patient safety.
• Optimizing lead selection and implant technique can enhance the safety of the index procedure and long-term clinical management.